Health
The world is hungry for mRNA COVID vaccines like Pfizer’s. But we’re short of vital components – Australian Times
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to…
Archa Fox, The University of Western Australia and Pall Thordarson, UNSW
Given the AstraZeneca COVID-19 vaccine is no longer recommended for under-50s following news of very rare blood clots, Australia is looking to other vaccines to plug the gap.
Pfizers mRNA vaccine will become the mainstay of the rollout, with 40 million doses expected to arrive before years end.
But Australia isnt the only country eager to get its hand on this vaccine.
Skyrocketing demand coupled with shortages of vital components…
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoRush to buy homes before rate cuts send prices soaring
-
Business20 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025